Zenrock Laboratories Ltd provides a cryptocurrency custody platform that secures private keys with d Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2026-03-30 | £1.7M |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| 10T DAE 3.0 FUND, LPCORP | SERIES A | 961,445 | 40.8% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity ZENROCK LABORATORIES LTD raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. ZENROCK LABORATORIES LTD has 2 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
VOTING RIGHTS: HOLDERS OF NON-VOTING ORDINARY SHARES HAVE NO RIGHT TO RECEIVE NOTICE OF OR TO ATTEND, SPEAK OR VOTE AT ANY GENERAL MEETINGS OF THE COMPANY, NOR TO RECEIVE OR VOTE ON PROPOSED WRITTEN RESOLUTIONS OF THE COMPANY. DIVIDEND RIGHTS: HOLDERS OF NON-VOTING ORDINARY SHARES HAVE THE RIGHT TO DIVIDENDS. LIQUIDATION AND EXIT: SUBJECT TO THE HOLDERS OF SERIES A SHARES RECEIVING THE PREFERENCE AMOUNT FIRST, THE BALANCE OF THE SURPLUS ASSETS (IF ANY) SHALL BE DISTRIBUTED AMONG HOLDERS OF NON-VOTING ORDINARY SHARES ALONG WITH HOLDERS OF OTHER EQUITY SHARES PRO RATA TO THE NUMBER OF EQUITY SHARES HELD. THE NON-VOTING ORDINARY SHARES ARE NOT REDEEMABLE.
VOTING RIGHTS – THE SERIES A SHARES CONFER ON EACH HOLDER OF SERIES A SHARES THE RIGHT TO RECEIVE NOTICE OF AND TO ATTEND, SPEAK AND VOTE AT ALL GENERAL MEETINGS OF THE COMPANY, AND TO RECEIVE AND VOTE ON PROPOSED WRITTEN RESOLUTIONS OF THE COMPANY. PARTICIPATION IN A DISTRIBUTION (DIVIDENDS) – THE SERIES A SHARES CARRY FULL DIVIDEND RIGHTS. PARTICIPATION IN A DISTRIBUTION (CAPITAL) – ON A DEEMED LIQUIDATION EVENT, DISTRIBUTION OF ASSETS ON A LIQUIDATION OR A RETURN OF CAPITAL (OTHER THAN A CONVERSION, REDEMPTION OR PURCHASE OF SHARES), WHETHER THE SURPLUS ASSETS OF THE COMPANY REMAINING AFTER PAYMENT OF ITS LIABILITIES OR THE NET PURCHASE PRICE MADE AVAILABLE TO HOLDERS OF SHARES (INCLUDING ANY PORTION OF THE CONSIDERATION PAID IN CONNECTION WITH A DEEMED LIQUIDATION EVENT THAT IS SUBJECT TO AN ESCROW, HOLDBACK, EARN-OUT OR OTHER DEFERRAL OF PAYMENT OR CONTINGENCY, IN WHICH CASE THE CONSIDERATION SO DISTRIBUTED ON ANY FURTHER OCCASION SHALL BE PAID BY CONTINUING THE DISTRIBUTION FROM THE PREVIOUS DISTRIBUTION OF CONSIDERATION), SHALL BE APPLIED (TO THE EXTENT THAT THE COMPANY IS LAWFULLY
These are the directors and secretaries who have left ZENROCK LABORATORIES LTD. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.
| 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
7 more shareholders on file , sign up free to see.